Novel Coronavirus (2019-nCoV) Nucleic Acid Diagnostic Kit (PCR-Fluorescence Probing)

Novel Coronavirus (2019-nCoV) Nucleic Acid Diagnostic Kit (PCR-Fluorescence Probing)

Ordering Information

Cat. No. Mfr. No. Certificates Specification Price Quantity
MD01055690-01 S3104E CE-IVD, NMPA, FDA-EUA, Brazil ANVISA etc. 24 tests/kit, 48 tests/kit Inquiry

Add to Cart

    • Introduction
      • Introduction

        Coronavirus disease (COVID-19) is an infectious disease caused by a newly discovered coronavirus.

        Most people infected with the COVID-19 virus will experience mild to moderate respiratory illness and recover without requiring special treatment. Older people, and those with underlying medical problems like cardiovascular disease, diabetes, chronic respiratory disease, and cancer are more likely to develop serious illness.

    • Advantages
      • One-tube technology, extraction within 30minutes

        Up to 96 samples at one time

        Simple operation process, no need long term staff training

        Room temperature nucleic acid lysis, No heating

        Direct sample types include: Nasal, Throat, and Nasopharyngeal swabs

        Enhance screening efficiency

        Internal control: human housekeeping gene RNase P

    • Parameters
      • Technology: One-tube fast test/ Mag-beads

        Sensitivity: 200copies/mL

        Lysis: Room temperature lysis

        Sample types: Alveolar lavage fluid; throat swab, sputum
        (varys in different registration version)

    • Certificates
      • CE-IVD, NMPA, FDA-EUA, Brazil ANVISA etc.

        FDA-EUA: Instruction for Use and fact sheet for healthcare providers, fact sheet for patients are available at https://www.fda.gov/medical-devices/emergency-situations

Note: If you don't receive our verification email, do the following:

Copyright © Amerigo Scientific. All rights reserved.